| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2009 ( Subtotal = $0 ) |
| | 2009 | 2007 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | U01AI056514 | FAST-TRACK PRODUCTION OF A HEPTAVALENT BOTULINUM VACCINE | 000 | 5 | NIH | 9/7/2009 | $0 |
| | 2009 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | UC1AI062531 | VITRIFICATION-STABILIZED MULTIVALENT BOTULINUM VACCINES | 000 | 1 | NIH | 10/9/2008 | $0 |
| | 2009 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | UC1AI062538 | PHASE 2 TRIAL FOR VENEZUELAN EQUINE ENCEPHALITIS V3526 | 000 | 1 | NIH | 10/24/2008 | $0 |
| | 2009 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | UC1AI062531 | VITRIFICATION-STABILIZED MULTIVALENT BOTULINUM VACCINES | 001 | 1 | NIH | 3/10/2009 | $0 |
| | 2009 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | UC1AI062538 | PHASE 2 TRIAL FOR VENEZUELAN EQUINE ENCEPHALITIS V3526 | 001 | 1 | NIH | 3/19/2009 | $0 |
|
| Issue Date FY: 2007 ( Subtotal = $288,859 ) |
| | 2007 | 2007 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | U01AI056514 | FAST-TRACK PRODUCTION OF A HEPTAVALENT BOTULINUM VACCINE | 000 | 5 | NIH | 3/22/2007 | $288,859 |
|
| Issue Date FY: 2006 ( Subtotal = $2,813,296 ) |
| | 2006 | 2006 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | U01AI056514 | FAST-TRACK PRODUCTION OF A HEPTAVALENT BOTULINUM VACCINE | 000 | 4 | NIH | 3/29/2006 | $2,813,296 |
|
| Issue Date FY: 2004 ( Subtotal = $18,518,625 ) |
| | 2004 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | U01AI056514 | FAST-TRACK PRODUCTION OF A HEPTAVALENT BOTULINUM VACCINE | 000 | 2 | NIH | 1/30/2004 | $3,134,091 |
| | 2004 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | UC1AI062538 | PHASE 2 TRIAL FOR VENEZUELAN EQUINE ENCEPHALITIS V3526 | 000 | 1 | NIH | 9/10/2004 | $9,996,228 |
| | 2004 | 2004 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | UC1AI062531 | VITRIFICATION-STABILIZED MULTIVALENT BOTULINUM VACCINES | 000 | 1 | NIH | 8/30/2004 | $5,388,306 |
|
| Issue Date FY: 2003 ( Subtotal = $1,907,093 ) |
| | 2003 | 2003 | DYNPORT VACCINE COMPANY LLC | 64 THOMAS JEFFERSON DRIVE | FREDERICK | MD | 21702 | FREDERICK | USA | U01AI056514 | FAST-TRACK PRODUCTION OF A HEPTAVALENT BOTULINUM VACCINE | 000 | 1 | NIH | 8/28/2003 | $1,907,093 |
|
|
